Aug 29, 2016

Cardiocell’s stem cells via IV might be the answer in heart failure

Some chronic heart failure (HF) patients given an intravenous injection (IV) of specially prepared stem cells during a small phase IIa study saw significant functional and quality of life improvements associated with the treatment, Cardiocell LLC reported during the European Society of Cardiology Congress in Rome. SUBSCRIPTION REQUIRED TO READ FULL ARTICLE